Clinical Trial

A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)

Name: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) — clinical trial record (NCT05058040)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

A clinical study to evaluate the long-term safety of Sodium Oligomannate Capsules (GV-971)

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2021-09-16; most recent amendment 2025-01-22.

Status change: Recruiting → Active, Not Recruiting 2023-05-25

Trial Details

NCT Number	NCT05058040
Lead Sponsor	Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Conditions	Alzheimer Disease
Enrollment	2,500 participants
Start Date	2021-06-02
Primary Completion	2025-01 (estimated)
Study Completion	2025-04 (estimated)
Updated on ClinicalTrials.gov	2025-01-24